These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34750462)

  • 21. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Clin Chim Acta; 1999 Mar; 281(1-2):121-6. PubMed ID: 10217633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department.
    Karakiliç E; Kepez A; Abali G; Coşkun F; Kunt M; Tokgözoğlu L
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):143-9. PubMed ID: 20382614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystatin C and body surface area are major determinants of the ratio of N-terminal pro-brain natriuretic peptide to brain natriuretic peptide levels in children.
    Kurishima C; Masutani S; Kuwata S; Iwamoto Y; Saiki H; Ishido H; Tamura M; Senzaki H
    J Cardiol; 2015 Aug; 66(2):175-80. PubMed ID: 25498945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-Type Natriuretic Peptide and Hemoglobin are Two Major Factors Significantly Associated With Baseline Cerebral Oxygen Saturation Measured Using the INVOS Oximeter in Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery.
    Yamamoto M; Hayashida M; Kakemizu-Watanabe M; Ando N; Mukaida H; Kawagoe I; Yusuke S; Inada E
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):187-196. PubMed ID: 28778770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure.
    Hebl V; Zakharova MY; Canoniero M; Duprez D; Garcia S
    Vasc Health Risk Manag; 2012; 8():213-8. PubMed ID: 22536076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low triiodothyronine and exercise capacity in heart failure.
    Fontana M; Passino C; Poletti R; Zyw L; Prontera C; Scarlattini M; Clerico A; Emdin M; Iervasi G
    Int J Cardiol; 2012 Jan; 154(2):153-7. PubMed ID: 20888651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy.
    Kainuma S; Taniguchi K; Toda K; Shudo Y; Takeda K; Funatsu T; Miyagawa S; Kondoh H; Nishi H; Yoshikawa Y; Fukushima S; Hamada S; Kubo K; Daimon T; Sawa Y
    J Cardiol; 2015 Oct; 66(4):279-85. PubMed ID: 25851471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions.
    Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T;
    Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemoglobin level influences plasma brain natriuretic peptide concentration.
    Tsuji H; Nishino N; Kimura Y; Yamada K; Nukui M; Yamamoto S; Iwasaka T; Takahashi H
    Acta Cardiol; 2004 Oct; 59(5):527-31. PubMed ID: 15529559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain natriuretic peptide in acute myocardial infarction: a marker of cardio-renal interaction.
    Moltrasio M; Cosentino N; De Metrio M; Rubino M; Cabiati A; Milazzo V; Discacciati A; Marana I; Bonomi A; Veglia F; Lauri G; Marenzi G
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):803-9. PubMed ID: 26784574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between low T3 syndrome and NT-proBNP levels in non-cardiac patients.
    Pinelli M; Bindi M; Cassetti G; Moroni F; Pandolfo C; Rosada J; Castiglioni M
    Acta Cardiol; 2007 Feb; 62(1):19-24. PubMed ID: 17375888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure.
    Emdin M; Passino C; Prontera C; Iervasi A; Ripoli A; Masini S; Zucchelli GC; Clerico A
    Clin Chem Lab Med; 2004; 42(6):627-36. PubMed ID: 15259379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic value of admission B-type natriuretic peptide on outcome for patients with congestive heart failure].
    Deng XT; Shi GL; Wang RX; Zhao JX; Zheng JG; Bao YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):462-6. PubMed ID: 22943638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status.
    Pimenta J; Paulo C; Mascarenhas J; Gomes A; Azevedo A; Rocha-Gonçalves F; Bettencourt P
    Int J Cardiol; 2010 Nov; 145(2):209-214. PubMed ID: 19729213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events.
    Ueno H; Nakayama M; Kojima S; Kusuhara K; Nagayoshi Y; Yamamuro M; Nishijima T; Usuku H; Kaikita K; Sumida H; Yamabe H; Sugiyama S; Yoshimura M; Ogawa H
    Heart Vessels; 2008 Jul; 23(4):243-8. PubMed ID: 18649054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.